Autolus Therapeutics (AUTL) News Today $1.44 +0.04 (+2.48%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AUTL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Armistice Capital LLC Grows Position in Autolus Therapeutics PLC Sponsored ADR $AUTLSeptember 2 at 8:12 AM | marketbeat.comAffinity Asset Advisors LLC Cuts Stock Holdings in Autolus Therapeutics PLC Sponsored ADR $AUTLAugust 28, 2025 | marketbeat.comAutolus Therapeutics PLC Sponsored ADR $AUTL Shares Purchased by Wellington Management Group LLPAugust 26, 2025 | marketbeat.comNeedham Keeps Buy Rating on Autolus (AUTL) with a $10 TargetAugust 24, 2025 | msn.comEquities Analysts Set Expectations for AUTL Q3 EarningsAugust 17, 2025 | marketbeat.comAutolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Buy" by BrokeragesAugust 17, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Upgraded by Wall Street Zen to "Hold" RatingAugust 17, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Up 5.2% - Still a Buy?August 16, 2025 | marketbeat.comWhat is William Blair's Estimate for AUTL FY2029 Earnings?August 16, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Trading Down 3.5% Following Analyst DowngradeAugust 15, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Given New $5.00 Price Target at Wells Fargo & CompanyAugust 15, 2025 | marketbeat.comCetera Investment Advisers Raises Stock Position in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)August 15, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Releases Earnings Results, Beats Expectations By $0.06 EPSAugust 13, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Sees Unusually-High Trading Volume - Should You Buy?August 13, 2025 | marketbeat.comAutolus Therapeutics Reports Q2 2025 Financial ResultsAugust 13, 2025 | msn.comAutolus Therapeutics PLC (AUTL) Q2 2025 Earnings Call Highlights: Strong Product Sales Amid ...August 13, 2025 | finance.yahoo.comAutolus Therapeutics: Expanding The Reach Of Its CD19 Therapy, But Still Far From ProfitableAugust 12, 2025 | seekingalpha.comAutolus Therapeutics plc (AUTL) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comAutolus Therapeutics plc: Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business UpdatesAugust 12, 2025 | finanznachrichten.deAutolus Therapeutics plc 2025 Q2 - Results - Earnings Call PresentationAugust 12, 2025 | seekingalpha.comKnott David M Jr Purchases Shares of 420,000 Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)August 12, 2025 | marketbeat.comAutolus Therapeutics Reports Second Quarter 2025 Financial Results and Business UpdatesAugust 12, 2025 | globenewswire.comAutolus Therapeutics Q2 2025 Earnings PreviewAugust 12, 2025 | msn.comAutolus Therapeutics PLC (AUTL) Q2 2025 Earnings Report Preview: What To Look ForAugust 12, 2025 | finance.yahoo.comAutolus Therapeutics (AUTL) Expected to Announce Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comTruist Financial Maintains a Buy Rating on Autolus Therapeutics (AUTL)August 4, 2025 | msn.comBIT Capital GmbH Sells 437,620 Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)August 4, 2025 | marketbeat.comNeedham Maintains a Buy on Autolus Therapeutics (AUTL), Sets a $10 PTAugust 1, 2025 | msn.comAutolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025July 24, 2025 | globenewswire.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Still a Buy?July 21, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Receives Buy Rating from Needham & Company LLCJuly 21, 2025 | marketbeat.comAutolus Therapeutics' CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)July 21, 2025 | globenewswire.comAutolus Therapeutics plc: Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 | finanznachrichten.deAutolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 15, 2025 | finance.yahoo.comAutolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 15, 2025 | globenewswire.comAutolus Therapeutics (NASDAQ:AUTL) Shares Down 5.1% - Time to Sell?July 15, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Up 7.1% - Still a Buy?July 14, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Stock, Earnings Estimates, EPS, And Revenue - BenzingaJune 30, 2025 | benzinga.comAutolus Therapeutics Ltd (AUTL) Stock Forums - Investing.comJune 29, 2025 | investing.comAutolus Therapeutics (AUTL) Presents Positive Long-Term Obe-cel Data at EHA 2025June 29, 2025 | msn.comAutolus Therapeutics plc (AUTL) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comNeedham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10June 24, 2025 | msn.comAutolus Therapeutics (NASDAQ:AUTL) Trading 7.1% Higher - Should You Buy?June 23, 2025 | marketbeat.comBank of America Corp DE Reduces Stake in Autolus Therapeutics plc (NASDAQ:AUTL)June 17, 2025 | marketbeat.comWhat 4 Analyst Ratings Have To Say About Autolus TherapeuticsJune 13, 2025 | benzinga.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Down - Time to Sell?June 13, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Autolus Therapeutics (NASDAQ:AUTL)June 12, 2025 | marketbeat.comAutolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) CongressJune 12, 2025 | globenewswire.comAutolus Therapeutics (NASDAQ:AUTL) Trading Down 3.2% - Time to Sell?June 11, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Grows Stock Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)June 8, 2025 | marketbeat.com Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AUTL Media Mentions By Week AUTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUTL News Sentiment▼1.710.96▲Average Medical News Sentiment AUTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUTL Articles This Week▼24▲AUTL Articles Average Week Get the Latest News and Ratings for AUTL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Autolus Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Aurinia Pharmaceuticals News Today Travere Therapeutics News Today Ardelyx News Today WAVE Life Sciences News Today Tilray Brands News Today Edgewise Therapeutics News Today Phibro Animal Health News Today Harrow News Today Schrodinger News Today Avadel Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUTL) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AUTL Stock Alerts